Cargando…

The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae

BACKGROUND: Neisseria gonorrhoeae and Neisseria meningitidis are closely-related bacteria that cause a significant global burden of disease. Control of gonorrhoea is becoming increasingly difficult, due to widespread antibiotic resistance. While vaccines are routinely used for N. meningitidis, no va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Semchenko, Evgeny A, Tan, Aimee, Borrow, Ray, Seib, Kate L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743822/ https://www.ncbi.nlm.nih.gov/pubmed/30551148 http://dx.doi.org/10.1093/cid/ciy1061

Ejemplares similares

The Bexsero Neisseria meningitidis serogroup B vaccine antigen NHBA is a high-affinity chondroitin sulfate binding protein
por: Mubaiwa, Tsitsi D., et al.
Publicado: (2018)

The Neisseria gonorrhoeae Vaccine Candidate NHBA Elicits Antibodies That Are Bactericidal, Opsonophagocytic and That Reduce Gonococcal Adherence to Epithelial Cells
por: Semchenko, Evgeny A., et al.
Publicado: (2020)

Outer membrane vesicle vaccines for Neisseria gonorrhoeae
por: Semchenko, Evgeny A., et al.
Publicado: (2021)

MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies
por: Semchenko, Evgeny A., et al.
Publicado: (2017)

An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol
por: Thng, Caroline, et al.
Publicado: (2023)

Product review on the IMD serogroup B vaccine Bexsero®
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022)

Progressive Decrease in the Potential Usefulness of Meningococcal Serogroup B Vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern Spain
por: Pérez-Trallero, Emilio, et al.
Publicado: (2014)

The Neisseria gonorrhoeae Methionine Sulfoxide Reductase (MsrA/B) Is a Surface Exposed, Immunogenic, Vaccine Candidate
por: Jen, Freda E.-C., et al.
Publicado: (2019)

The glycointeractome of serogroup B Neisseria meningitidis strain MC58
por: Mubaiwa, Tsitsi D., et al.
Publicado: (2017)

Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation
por: Brehony, Carina, et al.
Publicado: (2016)

Intractable problems require novel solutions: it's time to get serious about developing a gonorrhoea vaccine
por: Semchenko, Evgeny A, et al.
Publicado: (2016)

Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBA
por: Maritan, Martina, et al.
Publicado: (2017)

A comparison of national vaccination policies to prevent serogroup B meningococcal disease
por: Sulis, Giorgia, et al.
Publicado: (2022)

Self-Inhibitory Peptides Targeting the Neisseria gonorrhoeae MtrCDE Efflux Pump Increase Antibiotic Susceptibility
por: Evert, Benjamin J., et al.
Publicado: (2022)

Glycointeractome of Neisseria gonorrhoeae: Identification of Host Glycans Targeted by the Gonococcus To Facilitate Adherence to Cervical and Urethral Epithelial Cells
por: Semchenko, Evgeny A., et al.
Publicado: (2019)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
por: Rivero-Calle, Irene, et al.
Publicado: (2019)

Ecologic Study of Meningococcal B Vaccine and Neisseria gonorrhoeae Infection, Norway
por: Whelan, Jane, et al.
Publicado: (2016)

Toward an Improved Meningococcal Serogroup B Assay
por: Poolman, Jan
Publicado: (2018)

The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae
por: Leduc, Isabelle, et al.
Publicado: (2020)

The Lst Sialyltransferase of Neisseria gonorrhoeae Can Transfer Keto-Deoxyoctanoate as the Terminal Sugar of Lipooligosaccharide: a Glyco-Achilles Heel That Provides a New Strategy for Vaccines to Prevent Gonorrhea
por: Jen, Freda E.-C., et al.
Publicado: (2021)

Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
por: McNeil, Lisa K., et al.
Publicado: (2018)

Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents
por: Vesikari, Timo, et al.
Publicado: (2016)

Adaptation of Neisseria gonorrhoeae to the Female Reproductive Tract
por: Song, Wenxia, et al.
Publicado: (2020)

Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis
por: Gasparini, Roberto, et al.
Publicado: (2016)

Editorial Commentary: The Endgame for Serogroup A Meningococcal Disease in Africa?
por: Maiden, Martin C. J.
Publicado: (2013)

Meningococcal Disease-Associated Prophage-Like Elements Are Present in Neisseria gonorrhoeae and Some Commensal Neisseria Species
por: Al Suwayyid, Barakat A, et al.
Publicado: (2020)

Direct detection and serogroup characterization of Neisseria meningitidis from outbreak of meningococcal meningitis in Delhi
por: Negi, SS, et al.
Publicado: (2010)

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
por: Ruiz García, Yara, et al.
Publicado: (2021)

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018
por: Loenenbach, Anna D, et al.
Publicado: (2020)

Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine
por: de Voer, Richarda M., et al.
Publicado: (2010)

Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England
por: Ladhani, Shamez N., et al.
Publicado: (2016)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
por: Hong, Eva, et al.
Publicado: (2016)

Carriage of Neisseria meningitidis Serogroup W135 ST-2881
por: Boisier, Pascal, et al.
Publicado: (2006)

Meningococcal disease serogroup C
por: Dickinson, Félix O, et al.
Publicado: (2012)

Interactions between Loci Contributing to Antimicrobial Resistance and Virulence in Neisseria gonorrhoeae
por: Mortimer, Tatum D.
Publicado: (2022)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016)

Persistent low carriage of serogroup A Neisseria meningitidistwo years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac
por: Kristiansen, Paul A, et al.
Publicado: (2014)

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16
por: Findlow, Helen, et al.
Publicado: (2019)

The sweet side of the pathogenic Neisseria: the role of glycan interactions in colonisation and disease
por: Mubaiwa, Tsitsi D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e5fu6mn6o237scre0a2p2686ni